Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Thursday, March 31, 2022
US FDA News: Magellan Diagnostics Recalls LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests Due to Risk of Falsely Low Results
The LeadCare tests are used to detect blood lead level but has risk of falsely low results.
Read more:
Magellan Diagnostics Recalls LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests Due to Risk of Falsely Low Results
Newer Post
Older Post
Home